Ken Kudura
Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
Nordmann T, Messerli-Odermatt O, Meier L, Micaletto S, Coppetti T, Nägeli M, Kamarachev J, Kudura K, Freiberger S, Rordorf T, Mangana J, Braun R, Dummer R. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease. Oncotarget 2019; 10:6647-6650.
19.11.2019Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2 mutated extramammary Paget's disease.
19.11.2019Oncotarget 2019; 10:6647-6650
Nordmann Thierry M, Messerli-Odermatt Olivia, Meier Larissa, Micaletto Sara, Coppetti Thomas, Nägeli Mirjam, Kamarachev Jivko, Kudura Ken, Freiberger Sandra N, Rordorf Tamara, Mangana Joanna, Braun Ralph, Dummer Reinhard
Maximum Standardized Uptake Value (SUV) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer
Morand G, Vital D, Kudura K, Werner J, Stöckli S, Huber G, Huellner M. Maximum Standardized Uptake Value (SUV) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer. Sci Rep 2018; 8:11817.
07.08.2018Maximum Standardized Uptake Value (SUV) of Primary Tumor Predicts Occult Neck Metastasis in Oral Cancer
07.08.2018Sci Rep 2018; 8:11817
Morand Grégoire B, Vital Domenic G, Kudura Ken, Werner Jonas, Stöckli Sandro, Huber Gerhard, Huellner Martin W